Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027

$4,950$7,250

Description

Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027

Market Overview

Worldwide it has been noticed that the cardiovascular information system market possesses a USD 1,560.93 million during the conjecture time of 2020 to 2027. It has been denoted that the cardiovascular information system market projects at a CAGR of 8.23%. Everywhere, it has been found that because of cardiovascular sickness many individuals have passed on because of heart-related infections.
The significant market driving elements are the ascent in the need to join CVIS with CPAS/EMR and different modules connected with cardiology to build the cardiovascular information system market size. Driving elements like interoperability, getting to the remote pictures and information, and limiting the responsibility of the IT area from the online emergency clinic is assisting in growing the cardiovascular information system with marketing size. The reception of CVIS coordinated arrangements because of its huge purchasing force of well-known emergency clinics and facilities expands the size of the cardiovascular information system market in this end-client order.

Market Segmentation

Based on type, the cardiovascular information system market is separated into CVIS and C-PACS. The CVIS division involves a huge market share from estimated time of 2015 to 2020. The CVIS area examines the information well and empowers the specialists to complete the ideal choice in very little time. In view of sections, the market is separated into programming, administration, and equipment.
Innovation progression of innovation prompted the utilization of imaging strategies for the treatment of related messes. Cutting-edge innovation has assisted in unique announcing of the pictures in the cardiovascular information system with marketing which has helped in conveying the reports of the patients.

Regional analysis

The cardiovascular information system market is extended to a great extent to the districts of North America coming after the European locale. Topographically, it has been denoted that this North American district is predominantly involved by severe protection and security guidelines and ascend in the extension of business in the cardiovascular information area. Universally, the North American locale has a medical services information system that has fostered its organization with merchants. Latin America is supposed to be somewhat in reverse than other arising nations yet is as yet encountering enormous potential for cardiovascular information system market development during the market figure period.

Major Players

The major market players of the global cardiovascular information system are GE, Koninklijke Philips N.V., McKesson Corporation, Siemens Healthineers, IBM Watson Health, Fujifilm Holdings Corporation, and Cerner Corporation.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

LIST OF CONTENTS

1 EXECUTIVE SUMMARY 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 MARKET STRUCTURE 19

2.4 ASSUMPTIONS & LIMITATIONS 20

3 RESEARCH METHODOLOGY 21

3.1 DATA MINING 21

3.2 SECONDARY RESEARCH 22

3.3 PRIMARY RESEARCH 23

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

3.6.1 BOTTOM-UP APPROACH 27

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30

4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30

4.2.3 TECHNOLOGICAL ADVANCEMENTS 30

4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31

4.3 RESTRAINTS 32

4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32

4.3.2 RESTRAINT IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 32

4.4.1 EMERGING MARKETS OF CVIS 32

5 MARKET FACTOR ANALYSIS 33

5.1 VALUE CHAIN ANALYSIS 33

5.1.1 R&D 34

5.1.2 MANUFACTURING 34

5.1.3 DISTRIBUTION AND SALES 34

5.1.4 POST-SALES MONITORING 34

5.2 PORTER’S FIVE FORCES MODEL 35

5.2.1 BARGAINING POWER OF SUPPLIERS 35

5.2.2 BARGAINING POWER OF BUYERS 36

5.2.3 THREAT OF NEW ENTRANTS 36

5.2.4 THREAT OF SUBSTITUTES 36

5.2.5 INTENSITY OF RIVALRY 36

5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36

5.3.1 OVERVIEW 36

5.3.2 IMPACT ON PRIVACY 37

5.3.3 IMPACT ON TECHNOLOGY 37

5.3.4 IMPACT ON DEMAND 37

6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38

6.1 OVERVIEW 38

6.2 SOFTWARE 39

6.3 SERVICES 39

6.4 HARDWARE 40

7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41

7.1 OVERVIEW 41

7.2 CLOUD-BASED/WEB-BASED 42

7.3 ON-PREMISE 42

8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43

8.1 OVERVIEW 43

8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44

8.3 ECHOCARDIOGRAPHY 45

8.4 HEMODYNAMICS MONITORING 45

8.5 ELECTROPHYSIOLOGY 46

8.6 VASCULAR ULTRASOUND 46

8.7 NUCLEAR CARDIOLOGY 47

8.8 ECG/STRESS/HOLTER MANAGEMENT 47

8.9 OTHERS 48

9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49

9.1 OVERVIEW 49

9.2 HOSPITAL & CLINICS 50

9.3 DIAGNOSTIC LABORATORIES 50

9.4 CARDIAC CATH LABS 51

9.5 OTHERS 51

10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52

10.1 OVERVIEW 52

10.2 AMERICAS 53

10.3 NORTH AMERICA 56

10.3.1 US 58

10.3.2 CANADA 59

10.3.3 LATIN AMERICA 61

10.4 EUROPE 63

10.4.1 WESTERN EUROPE 65

10.4.1.1 GERMANY 68

10.4.1.2 FRANCE 69

10.4.1.3 UK 71

10.4.1.4 ITALY 72

10.4.1.5 SPAIN 74

10.4.1.6 REST OF WESTERN EUROPE 76

10.4.2 EASTERN EUROPE 77

10.5 ASIA-PACIFIC 79

10.5.1 CHINA 81

10.5.2 INDIA 83

10.5.3 JAPAN 84

10.5.4 AUSTRALIA 86

10.5.5 SOUTH KOREA 87

10.5.6 REST OF ASIA-PACIFIC 89

10.6 MIDDLE EAST & AFRICA 90

10.6.1 MIDDLE EAST 93

10.6.2 AFRICA 94

11 COMPETITIVE LANDSCAPE 96

11.1 OVERVIEW 96

11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96

11.3 COMPETITIVE BENCHMARKING 97

11.4 COMPETITOR DASHBOARD 98

11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98

11.5.1 ACQUISITION 98

11.5.2 COLLABORATION 99

11.5.3 PRODUCT LAUNCH 99

11.5.4 PARTNERSHIP 99

11.6 FINANCIAL MATRIX 100

12 COMPANY PROFILES 101

12.1 GE HEALTHCARE 101

12.1.1 COMPANY OVERVIEW 101

12.1.2 FINANCIAL OVERVIEW 102

12.1.3 PRODUCTS/SERVICES OFFERED 102

12.1.4 KEY DEVELOPMENTS 103

12.1.5 SWOT ANALYSIS 103

12.1.6 KEY STRATEGIES 103

12.2 SIEMENS HEALTHINEERS 104

12.2.1 COMPANY OVERVIEW 104

12.2.2 FINANCIAL OVERVIEW 105

12.2.3 PRODUCTS/SERVICES OFFERED 105

12.2.4 KEY DEVELOPMENTS 106

12.2.5 SWOT ANALYSIS 106

12.2.6 KEY STRATEGIES 106

12.3 KONINKLIJKE PHILIPS NV 107

12.3.1 COMPANY OVERVIEW 107

12.3.2 FINANCIAL OVERVIEW 108

12.3.3 PRODUCTS/SERVICES OFFERED 108

12.3.4 KEY DEVELOPMENTS 109

12.3.5 SWOT ANALYSIS 109

12.3.6 KEY STRATEGIES 109

12.4 FUJIFILM HOLDINGS CORPORATION 110

12.4.1 COMPANY OVERVIEW 110

12.4.2 FINANCIAL OVERVIEW 111

12.4.3 PRODUCTS/SERVICES OFFERED 111

12.4.4 KEY DEVELOPMENTS 112

12.4.5 SWOT ANALYSIS 112

12.4.6 KEY STRATEGIES 112

12.5 MCKESSON CORPORATION 113

12.5.1 COMPANY OVERVIEW 113

12.5.2 FINANCIAL OVERVIEW 114

12.5.3 PRODUCTS/SERVICES OFFERED 114

12.5.4 KEY DEVELOPMENTS 115

12.5.5 SWOT ANALYSIS 115

12.5.6 KEY STRATEGIES 116

12.6 CERNER CORPORATION 117

12.6.1 COMPANY OVERVIEW 117

12.6.2 FINANCIAL OVERVIEW 117

12.6.3 PRODUCTS OFFERED 118

12.6.4 KEY DEVELOPMENTS 118

12.6.5 SWOT ANALYSIS 119

12.6.6 KEY STRATEGIES 119

12.7 IBM WATSON HEALTH 120

12.7.1 COMPANY OVERVIEW 120

12.7.2 FINANCIAL OVERVIEW 121

12.7.3 PRODUCTS OFFERED 121

12.7.4 KEY DEVELOPMENTS 122

12.7.5 SWOT ANALYSIS 122

12.7.6 KEY STRATEGIES 123

12.8 LUMEDX 124

12.8.1 COMPANY OVERVIEW 124

12.8.2 FINANCIAL OVERVIEW 124

12.8.3 PRODUCTS OFFERED 124

12.8.4 KEY DEVELOPMENTS 124

12.8.5 SWOT ANALYSIS 125

12.8.6 KEY STRATEGIES 125

12.9 AGFA-GEVAERT N.V. 126

12.9.1 COMPANY OVERVIEW 126

12.9.2 FINANCIAL OVERVIEW 126

12.9.3 PRODUCTS OFFERED 126

12.9.4 KEY DEVELOPMENTS 127

12.9.5 SWOT ANALYSIS 127

12.9.6 KEY STRATEGIES 127

12.10 DIGISONICS INC. 128

12.10.1 COMPANY OVERVIEW 128

12.10.2 FINANCIAL OVERVIEW 128

12.10.3 PRODUCTS OFFERED 128

12.10.4 KEY DEVELOPMENTS 128

12.10.5 SWOT ANALYSIS 129

12.10.6 KEY STRATEGIES 129

12.11 CARESTREAM HEALTH 130

12.11.1 COMPANY OVERVIEW 130

12.11.2 FINANCIAL OVERVIEW 130

12.11.3 PRODUCTS/SERVICES OFFERED 130

12.11.4 KEY DEVELOPMENTS 130

12.11.5 SWOT ANALYSIS 131

12.11.6 KEY STRATEGIES 131

12.12 EPIC SYSTEMS CORPORATION 132

12.12.1 COMPANY OVERVIEW 132

12.12.2 FINANCIAL OVERVIEW 132

12.12.3 PRODUCTS OFFERED 132

12.12.4 KEY DEVELOPMENTS 132

12.12.5 SWOT ANALYSIS 133

12.12.6 KEY STRATEGIES 133

12.13 SCIMAGE, INC. 134

12.13.1 COMPANY OVERVIEW 134

12.13.2 FINANCIAL OVERVIEW 134

12.13.3 PRODUCTS/SERVICES OFFERED 134

12.13.4 KEY DEVELOPMENTS 134

12.13.5 SWOT ANALYSIS 135

12.13.6 KEY STRATEGIES 135

13 APPENDIX 136

13.1 REFERENCES 136

13.2 RELATED REPORTS 136

Companies Mentioned

GE, Koninklijke Philips N.V., McKesson Corporation, Siemens Healthineers, IBM Watson Health, Fujifilm Holdings Corporation, and Cerner Corporation

Reviews

There are no reviews yet.

Be the first to review “Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027”

[class^="wpforms-"]
[class^="wpforms-"]